Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by B. Picandet
Efficacy of Benfluorex in Combination With Sulfonylurea in Type 2 Diabetic Patients: An 18-Week, Randomized, Double-Blind Study
Diabetes Care
Internal Medicine
Endocrinology
Advanced
Metabolism
Specialized Nursing
Diabetes
Related publications
A One-Year Multicentre, International, Randomised, Double-Blind Study With Comparison of Benfluorex Versus an Oral Anti-Diabetic in Combination With Sulfonylurea Administered Orally for the Treatment of Type Two Diabetes
Efficacy of Fixed-Dose Amlodipine and Losartan Combination Compared With Amlodipine Monotherapy in Stage 2 Hypertension: A Randomized, Double Blind, Multicenter Study
BMC Research Notes
Biochemistry
Medicine
Genetics
Molecular Biology
A Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Efficacy and Safety of Hydroxychloroquine in Patients With Type 2 Diabetes Mellitus
Global Journal of Endocrinological Metabolism
Propolis Supplementation Improves Glycemic and Antioxidant Status in Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Study
Complementary Therapies in Medicine
Alternative Medicine
Manual Therapy
Specialized Nursing
Advanced
Complementary
Rosiglitazone in Combination With Glimepiride Plus Metformin in Type 2 Diabetic Patients
Diabetes Care
Internal Medicine
Endocrinology
Advanced
Metabolism
Specialized Nursing
Diabetes
Anti-Hyperglycemic and Anti-Hyperlipidemic Effects of Lupinus Albus in Type 2 Diabetic Patients: A Randomized Double-Blind, Placebo-Controlled Clinical Trial
International Journal of Pharmacology
Pharmacology
Transglucosidase Improves the Bowel Movements in Type 2 Diabetes Mellitus Patients: A Preliminary Randomized Double-Blind, Placebo-Controlled Study
United European Gastroenterology Journal
Oncology
Gastroenterology
The Effect of Aggressive Versus Standard Lipid Lowering by Atorvastatin on Diabetic Dyslipidemia: The DALI Study: A Double-Blind, Randomized, Placebo-Controlled Trial in Patients With Type 2 Diabetes and Diabetic Dyslipidemia
Diabetes Care
Internal Medicine
Endocrinology
Advanced
Metabolism
Specialized Nursing
Diabetes
The SGLT2 Inhibitor Dapagliflozin Reduces Liver Fat but Does Not Affect Tissue Insulin Sensitivity: A Randomized, Double-Blind, Placebo Controlled Study With 8-Week Treatment in Type 2 Diabetes Patients
Diabetes Care
Internal Medicine
Endocrinology
Advanced
Metabolism
Specialized Nursing
Diabetes